Biolife Solutions (BLFS) Income from Continuing Operations (2010 - 2026)
Biolife Solutions' (BLFS) quarterly Income from Continuing Operations came in at 1186000.0 in Q1 2026, up 337.64% year-on-year from 271000.0 in Q1 2025, and down 66.24% on a QoQ basis from 3513000.0 in Q4 2025.
Biolife Solutions (BLFS) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 17 years of Income from Continuing Operations data on file, last reported at 1186000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 337.64% year-over-year to 1186000.0 in Q1 2026; TTM through Mar 2026 was 10518000.0, a 97.89% decrease from a year earlier, with the FY2025 full-year figure at 12130000.0, down 38.08% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 1186000.0, down from 3513000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for BLFS reached as high as 91004000.0 in Q4 2022 and fell as low as 72878000.0 in Q2 2022.
- Historically, Income from Continuing Operations has averaged 2105529.41 across 5 years, with a median of 3199000.0 in 2024.
- Across the five-year window, Income from Continuing Operations plunged 13159.49% in 2022 and jumped 689.44% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 91004000.0 in 2022, then plunged by 80.35% to 17886000.0 in 2023, then sank by 97.51% to 445000.0 in 2024, then soared by 689.44% to 3513000.0 in 2025, then sank by 66.24% to 1186000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 1186000.0 in Q1 2026, 3513000.0 in Q4 2025, and 621000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Biolife Solutions | 1.50 Bn | 1.42 Bn | 17.50 Mn | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 621,000.00 |
| Jun 30, 2025 | -15.84 Mn |
| Mar 31, 2025 | 271,000.00 |
| Dec 31, 2024 | 445,000.00 |
| Sep 30, 2024 | -471,000.00 |
| Jun 30, 2024 | -5.56 Mn |
| Mar 31, 2024 | -3.20 Mn |
| Dec 31, 2023 | 17.89 Mn |
| Sep 30, 2023 | -15.80 Mn |
| Jun 30, 2023 | -5.52 Mn |
| Mar 31, 2023 | -13.71 Mn |
| Dec 31, 2022 | 91.00 Mn |
| Sep 30, 2022 | -10.32 Mn |
| Jun 30, 2022 | -72.88 Mn |
| Mar 31, 2022 | -7.42 Mn |
| Dec 31, 2021 | -15.75 Mn |
| Sep 30, 2021 | 79,000.00 |
| Jun 30, 2021 | 7.88 Mn |